U.S. Markets open in 6 hrs 47 mins

Strength Seen in PTC Therapeutics (PTCT): Stock Surges 25.7%

Zacks Equity Research

PTC Therapeutics, Inc. (PTCT) was a big mover last session, as the company saw its shares rise by nearly 26% on the day. The move came on solid volume too, as far more shares changed hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $15.82 to $21.86 in the past one-month time frame.

The company has seen two positive revisions in the past two months. Besides, its earnings consensus has moved considerably higher over the same time frame, suggesting that more solid trading could be ahead for PTCT. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

PTC Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better performing Med-Drugs stocks include Elan Corporation, plc (ELN), Jazz Pharmaceuticals Public Limited Company (JAZZ) and Lannett Company, Inc. (LCI). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Read the Full Research Report on ELNRead the Full Research Report on JAZZRead the Full Research Report on PTCTRead the Full Research Report on LCIZacks Investment Research